Addiction Medicine

Addiction Medicine advances prevention, diagnosis, and treatment across the continuum of substance and behavioral addictions. This page distills the field into practical pathways you can use in clinics, hospitals, and community programs—screening and brief interventions that flag risk early; ASAM-aligned assessment to guide level of care; and person-centred plans that combine pharmacotherapy, psychotherapy, and recovery supports. If you’re exploring an Addiction Medicine Conference, you’re likely deciding how to translate guidelines into day-to-day choices: choosing medications, sequencing CBT/MI/CM, and coordinating warm handoffs so patients move safely from detox and stabilization to durable recovery. We emphasise measurable outcomes—retention, craving reduction, functioning, and quality of life—and show how registries, parity policies, and QI cycles can raise performance without adding friction for teams or patients. Because co-occurring mental and physical conditions are the norm, care models here foreground collaboration with psychiatry, primary care, nursing, pharmacy, and peers to align safety, adherence, and access.

Implementation details matter. This session outlines MOUD and AUD pharmacotherapy selection, dosing, and monitoring—with attention to drug–drug interactions, hepatic/renal considerations, and long-acting formulations. Psychosocial interventions are matched to stage of change and risk profile, with relapse-prevention plans that operationalize trigger management, coping skills, and aftercare. Harm-reduction practices—naloxone distribution, safer-use education, and low-threshold entry—improve survival and engagement, especially when blended with stepped-care pathways. Special population adaptations cover adolescents, perinatal care, and older adults; equity and cultural responsiveness reduce stigma and structural barriers. The page also cross-links to related content such as Opioid Use Disorder so readers can dive deeper into induction strategies, retention, and outcome optimisation within integrated systems of care.

Key Competencies You’ll Gain

Clinical assessment & diagnosis

  • Structured screening and ASAM-aligned severity assessment
  • Differential diagnosis with co-occurring psychiatric/medical conditions

Pharmacotherapy selection & safety

  • Indications, dosing, and monitoring for MOUD and AUD medications
  • Managing drug–drug interactions, hepatic/renal impairment

Psychosocial treatments & relapse prevention

  • Matching CBT/MI/CM to stage of change and risk profile
  • Designing recovery plans, triggers management, and aftercare

System design & quality improvement

  • Building stepped-care pathways with warm handoffs
  • Using outcomes, registries, and parity policies to drive improvement

Practice Essentials & Implementation Tips

Screening & brief intervention (SBIRT)
Use validated tools (AUDIT-C, DAST-10) with brief motivational conversations; embed into intake workflows.

Medication-assisted treatment
Combine pharmacotherapy with psychosocial care and harm-reduction; address induction barriers and adherence.

Managing co-morbid mental health
Coordinate with psychiatry for depression, anxiety, PTSD, psychosis; align psychopharmacology with SUD meds.

Harm-reduction integration
Naloxone distribution, safer-use education, and low-threshold access improve retention and survival.

Special populations
Adapt protocols for adolescents, perinatal care, and older adults; consider physiology, guardianship, and consent.

Pain & addiction interface
Distinguish undertreated pain from OUD; employ multimodal analgesia and opioid stewardship principles.

Equity and cultural adaptation
Address stigma, language, and access barriers; co-design services with lived-experience partners.

Measuring what matters
Track retention, cravings, function, and quality of life—not just abstinence; use data for QI cycles.

Related Sessions You May Like

Join the Global Addiction Medicine & Mental Health Community

Connect with addiction specialists, psychiatrists, psychologists, neuroscientists, and mental health advocates worldwide. Share your clinical findings, prevention strategies, and therapeutic approaches, while exploring the latest advancements and innovative treatments supporting well-being across diverse populations.

Copyright 2024 Mathews International LLC All Rights Reserved

Watsapp
Top